Atlas Trials

Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate

Clinical trial NCT01319591 · COMPLETED

Trial details

NCT number
NCT01319591
Sponsor
Dana-Farber Cancer Institute
Status
COMPLETED
Study type
OBSERVATIONAL
CNS LymphomaCNS Involvement of Systemic Lymphoma
Start date
2011-03-01
Primary completion
2014-08-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.